venBio Partners LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001776382 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $519M (100.0% shares, 0.0% debt)

Holdings (7)

New Positions (2)

PBLS PARABILIS MEDICINES INC 27.8%

Value $144M Shares 5,266,697 Est. Cost — Unrealized —

ACHV ACHIEVE LIFE SCIENCE INC 7.4%

Value $38.62M Shares 5,914,720 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PBLS	PARABILIS MEDICINES INC	5,266,697	$144M	27.8%	—	—	COM	698955101
ACHV	ACHIEVE LIFE SCIENCE INC	5,914,720	$38.62M	7.4%	—	—	COM	004468500

Exited Positions (1)

ARTV ARTIVA BIOTHERAPEUTICS INC 0.7%

Value $3.422M Shares 531,337 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ARTV	ARTIVA BIOTHERAPEUTICS INC	531,337	$3.422M	0.7%	—	—	—	04317A107

Decreased Positions (1)

HRMY HARMONY BIOSCIENCES HLDGS IN 3.3%

Value $17.19M (+25.5%) Shares 472,194 (-3.5%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
HRMY	HARMONY BIOSCIENCES HLDGS IN	472,194 (-3.5%)	$17.19M (+25.5%)	3.3%	—	—	COM	413197104

Unchanged Positions (4)

PHVS PHARVARIS N V 30.9%

Value $161M Shares 4,643,430 Est. Cost — Unrealized —

ALMS ALUMIS INC 24.5%

Value $127M Shares 4,528,408 Est. Cost — Unrealized —

LYEL LYELL IMMUNOPHARMA INC 0.9%

Value $4.745M Shares 337,697 Est. Cost — Unrealized —

ALXO ALX ONCOLOGY HLDGS INC 5.1%

Value $26.67M Shares 12,884,638 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	PHARVARIS N V	4,643,430	$161M	30.9%	—	—	COM	N69605108
ALMS	ALUMIS INC	4,528,408	$127M	24.5%	—	—	COM	022307102
LYEL	LYELL IMMUNOPHARMA INC	337,697	$4.745M	0.9%	—	—	COM NEW	55083R203
ALXO	ALX ONCOLOGY HLDGS INC	12,884,638	$26.67M	5.1%	—	—	COM	00166B105